RU95109157A - ANTIHIPPERGLICEMICALLY EFFECTIVE PHARMACEUTICAL COMPOSITION - Google Patents

ANTIHIPPERGLICEMICALLY EFFECTIVE PHARMACEUTICAL COMPOSITION

Info

Publication number
RU95109157A
RU95109157A RU95109157/14A RU95109157A RU95109157A RU 95109157 A RU95109157 A RU 95109157A RU 95109157/14 A RU95109157/14 A RU 95109157/14A RU 95109157 A RU95109157 A RU 95109157A RU 95109157 A RU95109157 A RU 95109157A
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
antihipperglicemically
effective pharmaceutical
formula
physiologically acceptable
Prior art date
Application number
RU95109157/14A
Other languages
Russian (ru)
Other versions
RU2145857C1 (en
Inventor
Каан Эльберт
Циглер Дитер
Брюкнер Райнхард
Original Assignee
Кали-Хеми Фарма ГмбХ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4423177A external-priority patent/DE4423177A1/en
Application filed by Кали-Хеми Фарма ГмбХ filed Critical Кали-Хеми Фарма ГмбХ
Publication of RU95109157A publication Critical patent/RU95109157A/en
Application granted granted Critical
Publication of RU2145857C1 publication Critical patent/RU2145857C1/en

Links

Claims (2)

1. Применение 4-хлор-5-[(4,5-дигидро-1H--имидазол-2-ил)-амино[-6-метокси-2- метилпиримидина формулы (I):
Figure 00000001

и его физиологически приемлемых кислотно-аддитвных солей для получения фармацевтических композиций для лечения гипергликемий.1. The use of 4-chloro-5 - [(4,5-dihydro-1H - imidazol-2-yl) amino [-6-methoxy-2-methylpyrimidine of formula (I):
Figure 00000001

and its physiologically acceptable acid addition salts for the preparation of pharmaceutical compositions for the treatment of hyperglycemia. 2. Фармацевтическая композиция с противогипергликемической активностью, отличающийся тем, что она содержит эффективное количество соединения формулы I по п.1 или его физиологически приемлемых кислотно-аддитивных солей вместе с обычными фармацевтическими вспомогательными средствами. 2. Pharmaceutical composition with anti-hyperglycemic activity, characterized in that it contains an effective amount of the compound of formula I according to claim 1 or its physiologically acceptable acid additive salts together with conventional pharmaceutical auxiliaries.
RU95109157A 1994-07-01 1995-06-01 Antihyperglycaemic activity of pharmaceutical composition RU2145857C1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4423177A DE4423177A1 (en) 1994-07-01 1994-07-01 Antihyperglycemic drugs
DEP4423177.6 1994-07-01

Publications (2)

Publication Number Publication Date
RU95109157A true RU95109157A (en) 1997-11-27
RU2145857C1 RU2145857C1 (en) 2000-02-27

Family

ID=6522064

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95109157A RU2145857C1 (en) 1994-07-01 1995-06-01 Antihyperglycaemic activity of pharmaceutical composition

Country Status (23)

Country Link
US (1) US5712283A (en)
EP (1) EP0689837B1 (en)
JP (1) JP3841846B2 (en)
KR (1) KR100366130B1 (en)
CN (1) CN1092961C (en)
AT (1) ATE210444T1 (en)
AU (1) AU691580B2 (en)
CA (1) CA2152998C (en)
CZ (1) CZ287563B6 (en)
DE (2) DE4423177A1 (en)
DK (1) DK0689837T3 (en)
DZ (1) DZ1894A1 (en)
ES (1) ES2167385T3 (en)
FI (1) FI117374B (en)
HU (1) HU226946B1 (en)
IL (1) IL113411A (en)
NO (1) NO307029B1 (en)
NZ (1) NZ270990A (en)
PT (1) PT689837E (en)
RU (1) RU2145857C1 (en)
SK (1) SK282227B6 (en)
UA (1) UA27954C2 (en)
ZA (1) ZA954691B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2212294A1 (en) * 1995-02-28 1996-09-06 Beiersdorf-Lilly Gmbh Use of moxonidine for the treatment of atherosclerosis
WO1997046241A1 (en) * 1996-06-06 1997-12-11 Eli Lilly And Company Formulation and method for treating congestive heart failure
NO980546L (en) * 1997-02-11 1998-08-12 Lilly Co Eli Pharmaceuticals
DE19722322A1 (en) * 1997-05-28 1998-12-03 Solvay Pharm Gmbh Nephro-protective drug
JP2001520195A (en) * 1997-10-17 2001-10-30 イーライ・リリー・アンド・カンパニー Pharmaceutical enhancement
US6897019B1 (en) 1998-04-17 2005-05-24 Tufts College Methods for treating and preventing insulin resistance and related disorders
AU2727400A (en) * 1999-01-29 2000-08-18 Eli Lilly And Company Moxonidine salts
DE19911371A1 (en) 1999-03-15 2000-09-21 Solvay Pharm Gmbh Medicines for the treatment of functional disorders and diseases of the lower intestinal tract, in particular associated abdominal visceral pain
PL372695A1 (en) * 2002-06-19 2005-07-25 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
WO2005039639A2 (en) * 2003-10-10 2005-05-06 Solvay Pharmaceuticals Gmbh Pharmaceutical composition comprising a selective i1 imidazoline receptor agonist and an angiotensin ii receptor blocker
RU2542462C2 (en) * 2013-06-28 2015-02-20 Андрей Владиславович Струтынский Method for correction of crisis course of hypertensive disease and abdominal obesity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2849537C2 (en) * 1978-11-15 1983-03-17 Beiersdorf Ag, 2000 Hamburg Substituted 5- (2-imidazolin-2-yl) aminopyrimidines, processes for their preparation and pharmaceuticals containing them
US4323570A (en) * 1978-11-15 1982-04-06 Beiersdorf Aktiengesellschaft Substituted aminopyrimidines
FR2669927B1 (en) * 1990-11-29 1994-04-08 Adir Cie NOVEL GUANIDINE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Similar Documents

Publication Publication Date Title
RU2002109240A (en) The use of retigabin for neuropathic pain
RU93004970A (en) Derivatives of cycloalkyl-substituted glutaramide, their use, pharmaceutical composition
EA200001154A1 (en) SOLID COMPOSITIONS CONTAINING DERIVATIVES OF GAMMA-AMINO-OIL ACID, AND METHOD OF THEIR OBTAINING
EP2289521A3 (en) Compositions and methods for use in tergeting vascular destruction
RU95109157A (en) ANTIHIPPERGLICEMICALLY EFFECTIVE PHARMACEUTICAL COMPOSITION
EP0911331A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
DE68906609D1 (en) DOPAMIN PRECURRENT.
FI940696A (en) New pyrazine derivatives, their preparation and use
RU96109699A (en) GUANIDIDES OF ALKENILKARBONIC ACIDS, METHOD OF THEIR RECEIVING, CONTAINING THEIR MEDICATION OR DIAGNOSTIC TOOL
CA2057291A1 (en) A stable pharmaceutical composition of human calcitonin
KR960003729A (en) Drugs with antihyperglycemic action
RU93004535A (en) COMPOUNDS, METHOD OF OBTAINING AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS
MXPA01007210A (en) Therapeutic agent for parkinson's disease including function improving agent for astrocyte.
ATE159511T1 (en) DERIVATIVES OF N,N,N',N'-TETRA-SUBSTITUTED 1,2-ETHYLENEDIAMINE COMPOUNDS
EP0323146A3 (en) Dopamine-beta-hydroxylase inhibitors
EP0209843A3 (en) Benzylpiperazine compound, preparation thereof, pharmaceutical composition, and use
RU94021365A (en) DERIVATIVES OF METHYLPIPERAZINAZEPENINE, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION ON THEIR BASIS AND USE OF DERIVATIVES AS A PHARMACEUTICAL ACTIVE SUBSTANCE
RU97111095A (en) PREPARATION FOR PREVENTION AND TREATMENT OF ANIMAL ANIMAL HELMINTHES "ALBAMELIN"
US4783449A (en) Hydrosoluble pharmaceutical compositions containing salts of (-)cis-1,2-epoxypropylphosphonic acid with aminoacids
IL71068A (en) N-(3-trifluoromethylphenyl)-n'-propargyl-piperazine,its preparation and pharmaceutical compositions containing it
ES2102370T3 (en) ANTIPARASITIC COMPOSITION FOR ANIMAL USE.
RU95116403A (en) BIOLOGICALLY ACTIVE FOOD SUPPLEMENT "GLUTAPIRON", possessing anti-coronary and geroprotective action
RU2001121019A (en) The use of maxonidine for the treatment of post-infarction conditions
RU99108789A (en) INHIBITOR OF SUBEPITELIAL POGGENITS
NZ220539A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions